Search

Your search keyword '"Lochmuller, H."' showing total 387 results

Search Constraints

Start Over You searched for: Author "Lochmuller, H." Remove constraint Author: "Lochmuller, H."
387 results on '"Lochmuller, H."'

Search Results

1. The emerging spectrum of neurodevelopmental comorbidities in early-onset Spinal Muscular Atrophy

2. A Solve-RD ClinVar-based reanalysis of 1522 index cases from ERN-ITHACA reveals common pitfalls and misinterpretations in exome sequencing

3. MYTHO is a novel regulator of skeletal muscle autophagy and integrity

5. Treatabolome DB: linking gene and variants with treatments for rare diseases

6. E-Health & Innovation to Overcome Barriers in Neuromuscular Diseases. Report from the 1st eNMD Congress: Nice, France, March 22-23, 2019

7. Treatabolome database: current state and new developments towards enhancing rare disease treatment visibility

8. Correction: Solving unsolved rare neurological diseases—a Solve-RD viewpoint (European Journal of Human Genetics, (2021), 29, 9, (1332-1336), 10.1038/s41431-021-00901-1)

9. REGISTRIES AND CARE OF NMD

10. Treatabolome database: towards enhancing Rare Diseases’ treatment visibility

11. Bi-allelic variants in SPATA5L1 lead to intellectual disability, spastic-dystonic cerebral palsy, epilepsy, and hearing loss

12. Molecular characterisation of congenital myasthenic syndromes in Southern Brazil

14. Tumor necrosis factor receptor SF10A (TNFRSF10A) SNPs correlate with corticosteroid response in Duchenne muscular dystrophy

15. Treatabolome: a rare diseases treatment awareness project

16. TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy

17. A homozygous missense variant inTUBGCP2alter the g-tubulin ring complex leading to abnormal cortical development, pontocerebellar atrophy and altered myelination

18. Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy

19. 222nd ENMC International Workshop: Myotonic dystrophy, developing a European consortium for care and therapy, Naarden, The Netherlands, 1-2 July 2016

20. FSHD / OPMD / MYOTONIC DYSTROPHY

23. Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease (vol 13, 155, 2018)

24. LGMD2A: genotype–phenotype correlations based on a large mutational survey on the calpain 3 gene

25. The Position of Neuromuscular Patients in Shared Decision Making. Report from the 235th ENMC Workshop: Milan, Italy, January 19-20, 2018

26. Health-Related Quality of Life in Patients with Adult-Onset Myotonic Dystrophy Type 1: A Systematic Review

27. Genetic determinants of disease severity in the myotonic dystrophy type 1 OPTIMISTIC cohort

28. Increasing phenotypic annotation improves the diagnostic rate of exome sequencing in a rare neuromuscular disorder

29. MSH3 modifies somatic instability and disease severity in Huntington's and myotonic dystrophy type 1

30. Missense mutations of ACTA1 cause dominant congenital myopathy with cores

31. A tRN[A.sup.Ala] mutation causing mitochondrial myopathy clinically resembling myotonic dystrophy

32. Childhood onset mitochondrial myopathy and lactic acidosis caused by a stop mutation in the mitochondrial cytochrome c oxidase III gene. (Letter to JMG)

33. MITOCHONDRIAL OXODICARBOXYLATE CARRIER DEFICIENCY: METABOLIC MODELLING IDENTIFIES DISEASE MECHANISM

34. Tracking disease progression non-invasively in Duchenne and Becker muscular dystrophies

38. Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease

41. Facilitating orphan drug development: Proceedings of the TREAT-NMD International Conference, December 2015, Washington, DC, USA

43. International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases

44. CONGENITAL MYOPATHIES (CNM)

45. Clinical research activity in the Newcastle MRC Centre for Neuromuscular Disease

Catalog

Books, media, physical & digital resources